By reconsidering previously published data, Hamdane et al. were able to observe a strong correlation of high SPHK1 expression with HCC risk in patients with HVC-induced cirrhosis, even in subjects reaching the SVR, although treated with IFN-based therapies. This evidence concerns the gene SPHK1 and hepatocellular carcinoma.